Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Development & Bioavailability
  6.  » Improving Bioavailability Using PBPK Modeling & Parallel Formulation Screening
Icon of a document with a magnifying glass

Improving Bioavailability using PBPK Modeling & Parallel Formulation Screening

Summary: A team of bioavailability experts at Catalent used the in-house bioavailability enhancement platform, OptiForm® Solution Suite, to optimize and develop Phase 1 clinical formulation within a short timeline. Catalent’s global supply chain expertise was utilized for packaging and distributing clinical supplies to the site and, as a result, the target molecule went from early stage to Phase 1 in under nine months.

Click here to download case study.